• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿喉返神经再支配的长期疗效。

Long-Term Outcomes of Pediatric Laryngeal Reinnervation.

机构信息

Department of Otolarygnology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, U.S.A.

Pediatric Otolaryngology, Texas Children's Hospital, Houston, Texas, U.S.A.

出版信息

Laryngoscope. 2024 Dec;134(12):5006-5009. doi: 10.1002/lary.31667. Epub 2024 Aug 7.

DOI:10.1002/lary.31667
PMID:39109791
Abstract

OBJECTIVE

Pediatric nonselective laryngeal reinnervation (NSLR) has gained popularity in recent years; however, long-term outcomes have not been reported.

METHODS

Patients greater than 1 year post reinnervation were recruited. Families were asked to report Pediatric Voice-Related Quality of Life (PVRQOL) and provide an audio recording of connected speech. PVRQOL and voice measures were compared with preoperative and early postoperative outcomes (<12 months) using analysis of variance (ANOVA) for repeated measures and post hoc tests for linear trend.

RESULTS

Sixty-six patient families were contacted. Twelve patients responded with PVRQOL; six (50%) were female. Median age at surgery was 6.4 (range 1.9-15) and at follow-up 13.5 (range 10-18), with a median of 6.8 years (range 3-9.1) since surgery at follow-up. Mean preoperative PVRQOL was 68.1 (95% CI 52.3-84.0), early postoperative 86.5 (73.2-99.7), and long-term 90 (82.7-97.3). ANOVA showed no significant difference between values (p = 0.1228), but post hoc testing showed improving outcomes over time (p-for-trend 0.0304). PVRQOL was stable between early postoperative and long-term values (p = 0.3399). Four voice samples were adequate for analysis. Mean preoperative cepstral peak prominence (CPP) was 5.2 (95% CI 3.4-7.0), early postoperative 8.5 (5.5-11.5), and long-term 6.8 (2.77-10.89, p = 0.3340, p-for-trend 0.2988) Low-to-high spectral ratio was 22.3 preoperatively (14.0-30.5), 23.0 early postoperative (17.4-28.7), and 28.8 long-term (17.4-40.2, p = 0.1174, p-for-trend 0.0364). Cepstral spectral index of dysphonia (CSID) was 83.0 preoperatively (44.1-121.8), 39.4 early postoperative (20.4-58.3), and 45.53 long-term (-0.05-91.1, p = 0.4457, p-for-trend 0.1464).

CONCLUSIONS

Years after NSLR, PVRQOL, low-to-high spectral ratio, and CSID show no evidence of degradation over time.

LEVEL OF EVIDENCE

4 Laryngoscope, 134:5006-5009, 2024.

摘要

目的

小儿非选择性喉返神经再支配(NSLR)近年来越来越受欢迎,但尚未报道其长期结果。

方法

招募术后大于 1 年的患者。要求家属报告小儿嗓音相关生活质量(PVRQOL),并提供连接语音的录音。使用重复测量方差分析(ANOVA)和事后检验线性趋势,将 PVRQOL 和嗓音测量结果与术前和早期术后(<12 个月)结果进行比较。

结果

共联系了 66 名患者家属。12 名患者对 PVRQOL 做出了回应,其中 6 名(50%)为女性。手术时的中位年龄为 6.4 岁(范围 1.9-15 岁),随访时为 13.5 岁(范围 10-18 岁),随访时手术中位时间为 6.8 年(范围 3-9.1 年)。术前 PVRQOL 的平均得分为 68.1(95%CI 52.3-84.0),早期术后为 86.5(73.2-99.7),长期为 90(82.7-97.3)。方差分析显示数值之间无显著差异(p=0.1228),但事后检验显示随时间推移结果有所改善(p 趋势=0.0304)。早期术后和长期 PVRQOL 值之间稳定(p=0.3399)。有 4 个语音样本可供分析。术前平均倒频谱峰突出度(CPP)为 5.2(95%CI 3.4-7.0),早期术后为 8.5(5.5-11.5),长期为 6.8(2.77-10.89,p=0.3340,p 趋势=0.2988)。低-高光谱比术前为 22.3(14.0-30.5),早期术后为 23.0(17.4-28.7),长期为 28.8(17.4-40.2,p=0.1174,p 趋势=0.0364)。嗓音障碍的倒频谱谱指数(CSID)术前为 83.0(44.1-121.8),早期术后为 39.4(20.4-58.3),长期为 45.53(-0.05-91.1,p=0.4457,p 趋势=0.1464)。

结论

在 NSLR 后数年,PVRQOL、低-高光谱比和 CSID 均未随时间出现退化迹象。

证据等级

4 级喉镜,134:5006-5009,2024。

相似文献

1
Long-Term Outcomes of Pediatric Laryngeal Reinnervation.小儿喉返神经再支配的长期疗效。
Laryngoscope. 2024 Dec;134(12):5006-5009. doi: 10.1002/lary.31667. Epub 2024 Aug 7.
2
Predictors of voice outcome in pediatric non-selective laryngeal reinnervation.儿童非选择性喉返神经再支配的嗓音结局预测因素。
Laryngoscope. 2020 Jun;130(6):1525-1531. doi: 10.1002/lary.28282. Epub 2019 Sep 9.
3
Long-Term Outcomes and Revision Rates in Laryngeal Reinnervation.喉返神经再支配的长期结果和翻修率。
Laryngoscope. 2024 Jul;134(7):3187-3192. doi: 10.1002/lary.31297. Epub 2024 Jan 27.
4
Nonselective Reinnervation as a Primary or Salvage Treatment of Unilateral Vocal Fold Palsy.非选择性神经再支配术作为单侧声带麻痹的主要或挽救性治疗。
Laryngoscope. 2020 Jul;130(7):1756-1763. doi: 10.1002/lary.28324. Epub 2019 Oct 21.
5
[Clinical analysis of 102 cases of pediatric vocal fold nodules].102例小儿声带小结的临床分析
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 Dec;37(12):943-947. doi: 10.13201/j.issn.2096-7993.2023.12.002.
6
Laryngeal reinnervation for paralytic dysphonia in children younger than 10 years.10岁以下儿童麻痹性发音障碍的喉再支配术
Arch Otolaryngol Head Neck Surg. 2012 Dec;138(12):1161-6. doi: 10.1001/jamaoto.2013.803.
7
Evaluation of pediatric voice handicap index and pediatric voice related quality of life before and after adenotonsillectomy in pediatric population.小儿腺样体扁桃体切除术前及术后小儿嗓音障碍指数及小儿嗓音相关生活质量的评估
Int J Pediatr Otorhinolaryngol. 2015 Mar;79(3):388-91. doi: 10.1016/j.ijporl.2014.12.034. Epub 2015 Jan 5.
8
Indirect vs Direct Voice Therapy for Children With Vocal Nodules: A Randomized Clinical Trial.间接嗓音治疗与直接嗓音治疗对声带小结患儿的疗效比较:一项随机临床试验
JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):156-163. doi: 10.1001/jamaoto.2017.2618.
9
Ten-year outcomes of recurrent laryngeal nerve reinnervation for thyroidectomy-related unilateral vocal fold paralysis: A single-surgeon, prospective study.甲状腺切除术相关单侧声带麻痹的喉返神经再支配的 10 年结果:单外科医生前瞻性研究。
Am J Otolaryngol. 2024 May-Jun;45(3):104242. doi: 10.1016/j.amjoto.2024.104242. Epub 2024 Feb 28.
10
Recurrent laryngeal nerve reinnervation in children: Acoustic and endoscopic characteristics pre-intervention and post-intervention. A comparison of treatment options.儿童喉返神经再支配:干预前后的声学和内镜特征。治疗方案比较。
Laryngoscope. 2015 Dec;125 Suppl 11:S1-15. doi: 10.1002/lary.25538. Epub 2015 Aug 8.

引用本文的文献

1
Laryngeal Reinnervation vs Type I Thyroplasty in Unilateral Vocal Fold Paralysis (VOCALIST): A Randomized Feasibility Study.喉返神经再支配术与Ⅰ型甲状软骨成形术治疗单侧声带麻痹的随机可行性研究(VOCALIST)
Laryngoscope. 2025 Sep;135(9):3320-3329. doi: 10.1002/lary.32230. Epub 2025 May 5.